{"id":6055,"date":"2026-07-18T12:48:47","date_gmt":"2026-07-18T12:48:47","guid":{"rendered":"https:\/\/knight-pharma.com\/web\/?page_id=6055"},"modified":"2026-07-18T12:48:48","modified_gmt":"2026-07-18T12:48:48","slug":"kpi-spira-60","status":"publish","type":"page","link":"https:\/\/knight-pharma.com\/web\/kpi-spira-60\/","title":{"rendered":"KPI SPIRA 60"},"content":{"rendered":"<div class=\"wp-block-image\">\n<figure class=\"alignright size-full\"><img fetchpriority=\"high\" decoding=\"async\" width=\"500\" height=\"500\" src=\"https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2026\/07\/KPI-SPIRA-60.png\" alt=\"\" class=\"wp-image-6062\" srcset=\"https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2026\/07\/KPI-SPIRA-60.png 500w, https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2026\/07\/KPI-SPIRA-60-300x300.png 300w, https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2026\/07\/KPI-SPIRA-60-150x150.png 150w, https:\/\/knight-pharma.com\/web\/wp-content\/uploads\/2026\/07\/KPI-SPIRA-60-200x200.png 200w\" sizes=\"(max-width: 500px) 100vw, 500px\" \/><\/figure>\n<\/div>\n\n\n<p class=\"wp-block-paragraph\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0);color:#cf2e2e\" class=\"has-inline-color\">COMPOSITION<\/mark><\/strong><br>Each ml contains:<br>Spiramycin &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 600,000 IU<br>Excipients ad &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 1 ml<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0);color:#cf2e2e\" class=\"has-inline-color\">INDICATIONS<\/mark><\/strong><br>Treatment of acute clinical mastitis in lactating cows caused by\u00a0<em>Staphylococcus aureus<\/em>\u00a0strains susceptible to spiramycin.<br>Treatment of respiratory infections caused by\u00a0<em>Pasteurella multocida<\/em>\u00a0and\u00a0<em>Mannheimia haemolytica<\/em>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0);color:#cf2e2e\" class=\"has-inline-color\">ADMINISTRATION AND DOSAGE<\/mark><\/strong><br>For intramuscular administration.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Body weight should be determined as accurately as possible to avoid underdosing.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Mastitis:<\/em><br>\u2022 30,000 IU spiramycin per kg body weight<br>(equivalent to 5 ml per 100 kg body weight)<br>\u2022 Administer&nbsp;<strong>twice<\/strong>&nbsp;at&nbsp;<strong>24\u2011hour intervals<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Respiratory infections:<\/em><br>\u2022 100,000 IU spiramycin per kg body weight<br>(equivalent to 5 ml per 30 kg body weight)<br>\u2022 Administer&nbsp;<strong>twice<\/strong>&nbsp;at&nbsp;<strong>48\u2011hour intervals<\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Do not administer more than&nbsp;<strong>15 ml per injection site<\/strong>.<br>If the dose must be divided, injections should be administered on&nbsp;<strong>opposite sides of the neck<\/strong>.<br>When more than two injections are required on the same side, maintain a minimum distance of&nbsp;<strong>15 cm<\/strong>&nbsp;between injection sites.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\">Failure to follow these instructions may result in residues exceeding the established maximum residue limit of&nbsp;<strong>200 \u00b5g\/kg in muscle<\/strong>.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0);color:#cf2e2e\" class=\"has-inline-color\">CONTRAINDICATIONS<\/mark><\/strong><br>Do not use in animals with known hypersensitivity to spiramycin.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0);color:#cf2e2e\" class=\"has-inline-color\">WITHDRAWAL PERIOD<\/mark><\/strong><\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Mastitis:<\/em><br>Meat and offal: 75 days<br>Milk: 13.5 days<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><em>Respiratory infections:<\/em><br>Meat and offal: 75 days<br>Milk: When used at the dosage required for respiratory infections, the product is&nbsp;<strong>not authorized<\/strong>&nbsp;for use in animals producing milk for human consumption.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong><mark style=\"background-color:rgba(0, 0, 0, 0);color:#cf2e2e\" class=\"has-inline-color\">STORAGE<\/mark><\/strong><br>Store below\u00a0<strong>30\u202f\u00b0C<\/strong>. Protect from light.<\/p>\n\n\n\n<p class=\"wp-block-paragraph\"><strong>FOR VETERINARY USE ONLY<\/strong><br><strong>KEEP OUT OF REACH OF CHILDREN<\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>COMPOSITIONEach ml contains:Spiramycin &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.. 600,000 IUExcipients ad &#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230; 1 ml INDICATIONSTreatment of acute clinical mastitis in lactating cows caused by\u00a0Staphylococcus aureus\u00a0strains susceptible to spiramycin.Treatment of respiratory infections caused by\u00a0Pasteurella multocida\u00a0and\u00a0Mannheimia haemolytica. ADMINISTRATION AND DOSAGEFor intramuscular administration. Body weight should be determined as accurately as possible to avoid underdosing. Mastitis:\u2022 30,000 &hellip;<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_monsterinsights_skip_tracking":false,"footnotes":""},"class_list":["post-6055","page","type-page","status-publish","hentry"],"_links":{"self":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/6055","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/comments?post=6055"}],"version-history":[{"count":1,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/6055\/revisions"}],"predecessor-version":[{"id":6063,"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/pages\/6055\/revisions\/6063"}],"wp:attachment":[{"href":"https:\/\/knight-pharma.com\/web\/wp-json\/wp\/v2\/media?parent=6055"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}